Ken Griffin Orphazyme A/S Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.56 - $2.72 $53,203 - $258,419
-95,007 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$2.41 - $4.91 $29,433 - $59,965
-12,213 Reduced 11.39%
95,007 $228,000
Q2 2021

Aug 16, 2021
BUY
$4.82 - $21.0 $516,800 - $2.25 Million
107,220 New
107,220 $788,000
Q4 2020

Feb 16, 2021
SELL
$8.96 - $12.2 $1.79 Million - $2.44 Million
-200,000 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$9.71 - $10.33 $1.94 Million - $2.07 Million
200,000 New
200,000 $2.07 Million

About Orphazyme A/S

ORPHY Quotes by TradingView
  • Ticker ORPHY
  • Exchange OTC
More about ORPHY
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email